ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

281
Analysis
Health Care • Japan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
•17 Dec 2018 08:01

Japan: Fortnightly Update - And So It Goes

AND SO IT GOES - After our eight-day 4.5% 'Thanksgiving rally', the market reverted to recent type and promptly fell 6.5% to Tuesday's low, which...

Logo
629 Views
Share
•04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
639 Views
Share
bullish•Daiichi Sankyo
•31 Oct 2018 16:19

Daiichi Sankyo 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Global Edoxaban sales increased ~64% y-o-y to ~¥52b, driven especially by brisk uptake in Japan (+53% to ~¥30b) and EU (+90% to...

bearish•Fast Retailing
•23 Jul 2018 07:38

JAPAN PASSIVE:  The Nikkei 225 Baskets if BOJ Changes

Last week in JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225 I discussed the BOJ's past and current ETF purchasing selection, ownership,...

Logo
805 Views
Share
bullish•Daiichi Sankyo
•28 Jun 2018 19:36

Series of R&D Positives After Recent Late Stage Setbacks, However, Too Early to Draw Firm Conclusion

Cost rationalization effort to drive industry leading earnings growth (on almost flat sales) over next 3-5 years. We reiterate our Neutral rating...

x